A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF <sup>V600E</sup> colorectal tumors
Ana Ruiz-Sáenz(CIC bioGUNE), Jean‐Philippe Coppé(University of California, San Francisco)
Cited by 0
Related Papers
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
|Unknown|2008|4.1k
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies
|Journal of Clinical Investigation|2023|43
Proteomic Analysis of Src Family Kinase Phosphorylation States in Cancer Cells Suggests Deregulation of the Unique Domain
|Molecular Cancer Research|2021|14
Metabolic Alterations driven by PFKFB3 upregulation confer Resistance to Trastuzumab in HER2-Positive Breast Cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0